Carl Knable

Carl Knable is the Director of Regulatory Affairs CMC at AbbVie, where they manage a team overseeing CMC post-approval variations and lead key marketed and development programs from a regulatory perspective. Prior to their current role, Carl held various engineering and regulatory positions at Abbott Laboratories, Pfizer, and Monsanto, gaining extensive experience in process development and technology transfer. They earned a degree in Chemical Engineering from the University of Illinois Urbana-Champaign. Previously, Carl served as Associate Director of Regulatory Affairs CMC at AbbVie, guiding CMC strategy for both clinical compounds and marketed products.